News + Filings Transactions Holdings
|
Flagship Ventures Fund IV General Partner LLC
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/11/2023 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 3.2M | $2.31 | $7.5M | By Flagship Pioneering Fund VII, L.P. | 07/11/2023 |
07/11/2023 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 1.1M | $2.31 | $2.5M | By Nutritional Health LTP Fund, L.P. | 07/11/2023 |
07/11/2023 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 1.1M | $2.31 | $2.5M | By Flagship Ventures Fund IV, L.P. | 07/11/2023 |
10/13/2022 | Axcella Health Inc. | AXLA | Purchase | Common Stock | 2.8M | $1.64 | $4.5M | By Flagship Ventures Fund IV, L.P. | 10/13/2022 |
10/13/2022 | Axcella Health Inc. | AXLA | Purchase | Common Stock | 914.6k | $1.64 | $1.5M | By Flagship Ventures Opportunities I, L.P. | 10/13/2022 |
10/13/2022 | Axcella Health Inc. | AXLA | Purchase | Common Stock | 919.1k | $1.64 | $1.5M | By Flagship Ventures Opportunities I, L.P. | 10/13/2022 |
10/13/2022 | Axcella Health Inc. | AXLA | Purchase | Common Stock | 3M | $1.64 | $5M | By FPA, L.P. | 10/13/2022 |
10/13/2022 | Axcella Health Inc. | AXLA | Purchase | Common Stock | 2.7M | $1.64 | $4.5M | By Flagship Ventures Fund IV, L.P. | 10/13/2022 |
05/27/2022 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 4.4M | $1.46 | $6.4M | By Flagship Ventures Fund IV, L.P. | 05/27/2022 |
05/27/2022 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 1.1M | $1.46 | $1.6M | By Flagship Ventures Fund IV-Rx, L.P. | 05/27/2022 |
05/27/2022 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 1.4M | $1.46 | $2M | By Flagship Ventures Opportunities Fund I, L.P. | 05/27/2022 |
05/27/2022 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 6.8M | $1.46 | $10M | By Nutritional Health LTP Fund, L.P. | 05/27/2022 |
05/27/2022 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 13.7M | $1.46 | $20M | By Flagship Pioneering Fund VII, L.P. | 05/27/2022 |
03/16/2022 | Axcella Health Inc. | AXLA | Purchase | Common Stock | 3.8M | $1.91 | $7.2M | By Flagship Ventures Fund IV, L.P. | 03/16/2022 |
03/16/2022 | Axcella Health Inc. | AXLA | Purchase | Common Stock | 947.9k | $1.91 | $1.8M | By Flagship Ventures Fund IV-Rx, L.P. | 03/16/2022 |
03/16/2022 | Axcella Health Inc. | AXLA | Purchase | Common Stock | 1.6M | $1.91 | $3M | By Flagship Ventures Opportunities I, L.P. | 03/16/2022 |
03/19/2021 | Rubius Therapeutics, Inc. | RUBY | Purchase | Common Stock | 70k | $29.00 | $2M | See Footnote | 03/19/2021 |
03/19/2021 | Rubius Therapeutics, Inc. | RUBY | Purchase | Common Stock | 70k | $29.00 | $2M | See Footnote | 03/19/2021 |
03/19/2021 | Rubius Therapeutics, Inc. | RUBY | Purchase | Common Stock | 70k | $29.00 | $2M | See Footnote | 03/19/2021 |
02/02/2021 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 37.1k | $15.00 | $557.1k | See Footnote | 02/02/2021 |
02/02/2021 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 9.3k | $15.00 | $139.3k | See Footnote | 02/02/2021 |
02/02/2021 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 37.1k | $15.00 | $557.1k | See Footnote | 02/02/2021 |
02/02/2021 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 46.4k | $15.00 | $696.4k | See Footnote | 02/02/2021 |
11/23/2020 | Seres Therapeutics, Inc. | MCRB | Other (disposition) | Common Stock | 3.6M | $0.00 | $0 | See Footnote | 11/23/2020 |
11/23/2020 | Seres Therapeutics, Inc. | MCRB | Other (disposition) | Common Stock | 642.2k | $0.00 | $0 | See Footnote | 11/23/2020 |
11/23/2020 | Seres Therapeutics, Inc. | MCRB | Other (disposition) | Common Stock | 966.2k | $0.00 | $0 | See Footnote | 11/23/2020 |
11/23/2020 | Seres Therapeutics, Inc. | MCRB | Other (disposition) | Common Stock | 1.2M | $0.00 | $0 | See Footnote | 11/23/2020 |
11/23/2020 | Seres Therapeutics, Inc. | MCRB | Other (disposition) | Common Stock | 1.5M | $0.00 | $0 | See Footnote | 11/23/2020 |
11/23/2020 | Seres Therapeutics, Inc. | MCRB | Other (disposition) | Common Stock | 43.2k | $0.00 | $0 | See Footnote | 11/23/2020 |
08/17/2020 | Moderna, Inc. | MRNA | Other (disposition) | Common Stock | 7.6M | $0.00 | $0 | See Footnote | 08/17/2020 |
08/17/2020 | Moderna, Inc. | MRNA | Other (disposition) | Common Stock | 1.4M | $0.00 | $0 | See Footnote | 08/17/2020 |
08/17/2020 | Moderna, Inc. | MRNA | Other (disposition) | Common Stock | 2.1M | $0.00 | $0 | See Footnote | 08/17/2020 |
06/29/2020 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 1.3M | $3.75 | $5M | See Footnote | 06/29/2020 |
06/29/2020 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 333.3k | $3.75 | $1.2M | See Footnote | 06/29/2020 |
06/29/2020 | Evelo Biosciences, Inc. | EVLO | Purchase | Common Stock | 1.3M | $3.75 | $5M | See Footnote | 06/29/2020 |
|
|